199 related articles for article (PubMed ID: 34997060)
1. A scoring system combining clinical, radiological, and histopathological examinations for differential diagnosis between lipoma and atypical lipomatous tumor/well-differentiated liposarcoma.
Asano Y; Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Yonezawa H; Araki Y; Morinaga S; Nojima T; Ikeda H; Tsuchiya H
Sci Rep; 2022 Jan; 12(1):237. PubMed ID: 34997060
[TBL] [Abstract][Full Text] [Related]
2. Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status.
Knebel C; Neumann J; Schwaiger BJ; Karampinos DC; Pfeiffer D; Specht K; Lenze U; von Eisenhart-Rothe R; Rummeny EJ; Woertler K; Gersing AS
BMC Cancer; 2019 Apr; 19(1):309. PubMed ID: 30943944
[TBL] [Abstract][Full Text] [Related]
3. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
[TBL] [Abstract][Full Text] [Related]
4. MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification.
Brisson M; Kashima T; Delaney D; Tirabosco R; Clarke A; Cro S; Flanagan AM; O'Donnell P
Skeletal Radiol; 2013 May; 42(5):635-47. PubMed ID: 22987247
[TBL] [Abstract][Full Text] [Related]
5. Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated?
Kilpatrick SE
Hum Pathol; 2024 May; 147():82-91. PubMed ID: 38135062
[TBL] [Abstract][Full Text] [Related]
6. Lessons learnt from MDM2 fluorescence in-situ hybridisation analysis of 439 mature lipomatous lesions with an emphasis on atypical lipomatous tumour/well-differentiated liposarcoma lacking cytological atypia.
Vargas AC; Joy C; Cheah AL; Jones M; Bonar F; Brookwell R; Garrone B; Talbot J; Harraway J; Gill AJ; Maclean FM
Histopathology; 2022 Jan; 80(2):369-380. PubMed ID: 34523152
[TBL] [Abstract][Full Text] [Related]
7. Developing a clinical scoring system to differentiate deep-seated atypical lipomatous tumor from lipoma of soft tissue.
Cheng Y; Ko AT; Huang JH; Lee BC; Yang RS; Liang CW; Tai HC; Cheng NC
Asian J Surg; 2019 Aug; 42(8):832-838. PubMed ID: 30711441
[TBL] [Abstract][Full Text] [Related]
8. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.
Jebastin JAS; Perry KD; Chitale DA; Mott MP; Sanchez J; Fritchie KJ; Palanisamy N; Williamson SR
Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
[TBL] [Abstract][Full Text] [Related]
10. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective.
Clay MR; Martinez AP; Weiss SW; Edgar MA
Am J Surg Pathol; 2016 Dec; 40(12):1647-1652. PubMed ID: 27508976
[TBL] [Abstract][Full Text] [Related]
11. Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma.
Erickson-Johnson MR; Seys AR; Roth CW; King AA; Hulshizer RL; Wang X; Asmann YW; Lloyd RV; Jacob EK; Oliveira AM
Mod Pathol; 2009 Dec; 22(12):1541-7. PubMed ID: 19820690
[TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma by cytological analysis.
Sugiyama K; Washimi K; Sato S; Hiruma T; Sakai M; Okubo Y; Miyagi Y; Yokose T
Diagn Cytopathol; 2022 Mar; 50(3):112-122. PubMed ID: 34984861
[TBL] [Abstract][Full Text] [Related]
13. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
[TBL] [Abstract][Full Text] [Related]
14. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors.
Zhang H; Erickson-Johnson M; Wang X; Oliveira JL; Nascimento AG; Sim FH; Wenger DE; Zamolyi RQ; Pannain VL; Oliveira AM
Am J Surg Pathol; 2010 Sep; 34(9):1304-11. PubMed ID: 20679883
[TBL] [Abstract][Full Text] [Related]
15. Dysplastic lipoma: potential diagnostic pitfall of using MDM2 RNA in situ hybridization to distinguish between lipoma and atypical lipomatous tumor.
Hung YP; Michal M; Dubuc AM; Rosenberg AE; Nielsen GP
Hum Pathol; 2020 Jul; 101():53-57. PubMed ID: 32439322
[TBL] [Abstract][Full Text] [Related]
16. Pilot study to differentiate lipoma from atypical lipomatous tumour/well-differentiated liposarcoma using MR radiomics-based texture analysis.
Pressney I; Khoo M; Endozo R; Ganeshan B; O'Donnell P
Skeletal Radiol; 2020 Nov; 49(11):1719-1729. PubMed ID: 32424704
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.
Kashima T; Halai D; Ye H; Hing SN; Delaney D; Pollock R; O'Donnell P; Tirabosco R; Flanagan AM
Mod Pathol; 2012 Oct; 25(10):1384-96. PubMed ID: 22699518
[TBL] [Abstract][Full Text] [Related]
18. MDM2 RNA In Situ Hybridization for the Diagnosis of Atypical Lipomatous Tumor: A Study Evaluating DNA, RNA, and Protein Expression.
Kulkarni AS; Wojcik JB; Chougule A; Arora K; Chittampalli Y; Kurzawa P; Mullen JT; Chebib I; Nielsen GP; Rivera MN; Ting DT; Deshpande V
Am J Surg Pathol; 2019 Apr; 43(4):446-454. PubMed ID: 30520819
[TBL] [Abstract][Full Text] [Related]
19. MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria.
Clay MR; Martinez AP; Weiss SW; Edgar MA
Am J Surg Pathol; 2015 Oct; 39(10):1433-9. PubMed ID: 26146760
[TBL] [Abstract][Full Text] [Related]
20. Quantitative signal intensity ratios to distinguish between subfascial lipoma and atypical lipomatous tumor/well-differentiated liposarcoma using short-tau inversion recovery (STIR) MRI.
Donners R; Krieg AH; Baumhoer D; Boll DT; Harder D
Diagn Interv Imaging; 2020 Jun; 101(6):383-390. PubMed ID: 32107197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
